Literature DB >> 20703892

Molecular basis of parathyroid hormone receptor signaling and trafficking: a family B GPCR paradigm.

Jean-Pierre Vilardaga1, Guillermo Romero, Peter A Friedman, Thomas J Gardella.   

Abstract

The parathyroid hormone (PTH) receptor type 1 (PTHR), a G protein-coupled receptor (GPCR), transmits signals to two hormone systems-PTH, endocrine and homeostatic, and PTH-related peptide (PTHrP), paracrine-to regulate different biological processes. PTHR responds to these hormonal stimuli by activating heterotrimeric G proteins, such as G(S) that stimulates cAMP production. It was thought that the PTHR, as for all other GPCRs, is only active and signals through G proteins on the cell membrane, and internalizes into a cell to be desensitized and eventually degraded or recycled. Recent studies with cultured cell and animal models reveal a new pathway that involves sustained cAMP signaling from intracellular domains. Not only do these studies challenge the paradigm that cAMP production triggered by activated GPCRs originates exclusively at the cell membrane but they also advance a comprehensive model to account for the functional differences between PTH and PTHrP acting through the same receptor.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20703892      PMCID: PMC3568769          DOI: 10.1007/s00018-010-0465-9

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  120 in total

Review 1.  Functional selectivity and classical concepts of quantitative pharmacology.

Authors:  Jonathan D Urban; William P Clarke; Mark von Zastrow; David E Nichols; Brian Kobilka; Harel Weinstein; Jonathan A Javitch; Bryan L Roth; Arthur Christopoulos; Patrick M Sexton; Keith J Miller; Michael Spedding; Richard B Mailman
Journal:  J Pharmacol Exp Ther       Date:  2006-06-27       Impact factor: 4.030

2.  G protein signaling in yeast: new components, new connections, new compartments.

Authors:  Janna E Slessareva; Henrik G Dohlman
Journal:  Science       Date:  2006-12-01       Impact factor: 47.728

Review 3.  Conformational complexity of G-protein-coupled receptors.

Authors:  Brian K Kobilka; Xavier Deupi
Journal:  Trends Pharmacol Sci       Date:  2007-07-13       Impact factor: 14.819

Review 4.  Mechanisms of anabolic therapies for osteoporosis.

Authors:  Ernesto Canalis; Andrea Giustina; John P Bilezikian
Journal:  N Engl J Med       Date:  2007-08-30       Impact factor: 91.245

5.  Contributions of parathyroid hormone (PTH)/PTH-related peptide receptor signaling pathways to the anabolic effect of PTH on bone.

Authors:  D Yang; R Singh; P Divieti; J Guo; M L Bouxsein; F R Bringhurst
Journal:  Bone       Date:  2007-02-16       Impact factor: 4.398

6.  Elevations in serum and urinary calcium with parathyroid hormone (1-84) with and without alendronate for osteoporosis.

Authors:  Diana M Antoniucci; Deborah E Sellmeyer; John P Bilezikian; Lisa Palermo; Kristine E Ensrud; Susan L Greenspan; Dennis M Black
Journal:  J Clin Endocrinol Metab       Date:  2006-12-12       Impact factor: 5.958

7.  NHERF-1 and the cytoskeleton regulate the traffic and membrane dynamics of G protein-coupled receptors.

Authors:  David Wheeler; W Bruce Sneddon; Bin Wang; Peter A Friedman; Guillermo Romero
Journal:  J Biol Chem       Date:  2007-06-27       Impact factor: 5.157

8.  Beta-arrestin-dependent parathyroid hormone-stimulated extracellular signal-regulated kinase activation and parathyroid hormone type 1 receptor internalization.

Authors:  W Bruce Sneddon; Peter A Friedman
Journal:  Endocrinology       Date:  2007-05-24       Impact factor: 4.736

9.  Occurrence of hypercalciuria in patients with osteoporosis treated with teriparatide.

Authors:  Paul D Miller; John P Bilezikian; Manuel Diaz-Curiel; Peiqi Chen; Fernando Marin; John H Krege; Mayme Wong; Robert Marcus
Journal:  J Clin Endocrinol Metab       Date:  2007-07-03       Impact factor: 5.958

Review 10.  Update in osteoporosis and metabolic bone disorders.

Authors:  Dolores Shoback
Journal:  J Clin Endocrinol Metab       Date:  2007-03       Impact factor: 5.958

View more
  52 in total

1.  G-protein-coupled receptor heteromer dynamics.

Authors:  Jean-Pierre Vilardaga; Luigi F Agnati; Kjell Fuxe; Francisco Ciruela
Journal:  J Cell Sci       Date:  2010-12-15       Impact factor: 5.285

Review 2.  Glucagon-like peptide 1 (GLP-1).

Authors:  T D Müller; B Finan; S R Bloom; D D'Alessio; D J Drucker; P R Flatt; A Fritsche; F Gribble; H J Grill; J F Habener; J J Holst; W Langhans; J J Meier; M A Nauck; D Perez-Tilve; A Pocai; F Reimann; D A Sandoval; T W Schwartz; R J Seeley; K Stemmer; M Tang-Christensen; S C Woods; R D DiMarchi; M H Tschöp
Journal:  Mol Metab       Date:  2019-09-30       Impact factor: 7.422

3.  On the evolution of development.

Authors:  John S Torday
Journal:  Trends Dev Biol       Date:  2014

4.  Disruption of β-catenin binding to parathyroid hormone (PTH) receptor inhibits PTH-stimulated ERK1/2 activation.

Authors:  Yanmei Yang; Bin Wang
Journal:  Biochem Biophys Res Commun       Date:  2015-06-03       Impact factor: 3.575

5.  The Concise Guide to PHARMACOLOGY 2013/14: G protein-coupled receptors.

Authors:  Stephen P H Alexander; Helen E Benson; Elena Faccenda; Adam J Pawson; Joanna L Sharman; Michael Spedding; John A Peters; Anthony J Harmar
Journal:  Br J Pharmacol       Date:  2013-12       Impact factor: 8.739

Review 6.  Minireview: More than just a hammer: ligand "bias" and pharmaceutical discovery.

Authors:  Louis M Luttrell
Journal:  Mol Endocrinol       Date:  2014-01-16

Review 7.  Role of DNA methylation in imprinting disorders: an updated review.

Authors:  Amr Rafat Elhamamsy
Journal:  J Assist Reprod Genet       Date:  2017-03-09       Impact factor: 3.412

8.  Critical role of parathyroid hormone (PTH) receptor-1 phosphorylation in regulating acute responses to PTH.

Authors:  Akira Maeda; Makoto Okazaki; David M Baron; Thomas Dean; Ashok Khatri; Mathew Mahon; Hiroko Segawa; Abdul B Abou-Samra; Harald Jüppner; Kenneth D Bloch; John T Potts; Thomas J Gardella
Journal:  Proc Natl Acad Sci U S A       Date:  2013-03-26       Impact factor: 11.205

Review 9.  Parathyroid hormone-related protein: an update.

Authors:  John J Wysolmerski
Journal:  J Clin Endocrinol Metab       Date:  2012-06-28       Impact factor: 5.958

10.  A high-content, live-cell, and real-time approach to the quantitation of ligand-induced β-Arrestin2 and Class A/Class B GPCR mobilization.

Authors:  Anthony P Leonard; Kathryn M Appleton; Louis M Luttrell; Yuri K Peterson
Journal:  Microsc Microanal       Date:  2013-01-28       Impact factor: 4.127

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.